Evidence map›Paper›PMID 20697201›Full record

ArticleCell cycle (Georgetown, Tex.)2010

Life without geminin.

Dimitris Karamitros, Panorea Kotantaki, Zoi Lygerou, Henrique Veiga-Fernandes, Vassilis Pachnis, Dimitris Kioussis, Stavros Taraviras

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dimitris KaramitrosDepartment of Physiology, Medical School, University of Patras, Patras, Greece. dkiouss@nimr.mrc.ac.uk
Panorea Kotantaki
Zoi Lygerou
Henrique Veiga-Fernandes
Vassilis Pachnis
Dimitris Kioussis
Stavros Taraviras
University of Patras · GR

Funding

Medical Research Council MC_U117537087
6 · The paper itself

Abstract

The interplay of proliferation and differentiation is essential for normal development and organogenesis. Geminin is a cell cycle regulator which controls licensing of origins for DNA replication, safeguarding genomic stability. Geminin has also been shown to regulate cellular decisions of self-renewal versus commitment of neuronal progenitor cells. We discuss here our recent analysis of mice with conditional inactivation of the Geminin gene in the immune system. Our data indicate that Geminin is not indispensable for every cell division: in the absence of Geminin, development of progenitor T cells appears largely unaffected. In contrast, rapid cell divisions, taking place in vitro upon TCR receptor activation or in vivo during homeostatic proliferation, are defective.

Indexed as

AnimalsCell Cycle ProteinsCell DifferentiationCell ProliferationChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA ReplicationG1 PhaseGemininGenomic InstabilityMiceNuclear ProteinsPolycomb-Group ProteinsRepressor ProteinsT-LymphocytesTranscription FactorsCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsGemininGmnn protein, mouseNuclear ProteinsPolycomb-Group ProteinsRepressor ProteinsRis2 protein, mouseSWI-SNF-B chromatin-remodeling complexTranscription Factors

Identifiers

PMID20697201
PMCPMC3041160
OpenAlexW2108879497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.